[Late failure of left ventricular leads stabilized using the retained guidewire technique in patients undergoing

Elena Arbelo1, Antonio García-Quintana, Eduardo Caballero

  • 1Servicio de Cardiología, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, España. elenaarbelo@secardiologia.es

Insights

The retained guidewire technique for stabilizing left ventricular leads may cause delayed electrode damage, including deformation and insulation deterioration, years after implantation. This method is not recommended due to potential long-term complications in cardiac resynchronization therapy.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Medical Device Technology

Context:

  • Cardiac resynchronization therapy (CRT) involves lead placement.
  • Repetitive dislocation of the left ventricular (LV) lead can complicate CRT procedures.
  • The retained guidewire technique was explored as a solution for lead stabilization.

Purpose:

  • To evaluate the long-term safety and efficacy of the retained guidewire technique for LV lead stabilization.
  • To investigate potential complications associated with this technique in CRT patients.

Summary:

  • The retained guidewire technique was used in 3 out of 185 CRT patients (1.6%) due to recurrent LV lead dislocation.
  • While initial parameters were normal, delayed issues (6 months-1 year) included elevated impedance, sensing/pacing changes, electrode deformation, fracture, and insulation deterioration.
  • Macroscopic dislocation was not evident, but material degradation was confirmed via laboratory analysis.

Impact:

  • The retained guidewire technique is associated with significant delayed electrode damage.
  • This technique should be avoided in CRT procedures to prevent long-term lead complications.
  • Findings highlight the need for careful consideration of lead stabilization methods and long-term device integrity.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...